Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...

NICE judged that ‘more data is needed to be certain that these technologies do not incorrectly detect or miss skin cancer in ...

Palantir is leveraging its Ontology system to scale commercial and government contracts, driving significant AI adoption and ...

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, but how do chatbots do when the ...

It's my pleasure today to be in conversation with Reid Hoffman, the co-founder of LinkedIn and the author of a new book, "Superagency: What Could Possibly Go Right With Our AI Future?" ...

Generative artificial intelligence (genAI) has become assimilated into the education, research, and clinical domains of nuclear medicine and health care. Understanding the principles, limitations, and ...

The FDA has granted 510(k) clearance to AI Optics’ Sentinel Camera, a handheld retinal imaging system that captures ...

The words "artificial intelligence" are now ubiquitous, their influence having risen dramatically in recent years and their ...

The analytics of AI & connectivity of IoT create an opportunity as well as a challenge for the next generation of patient ...

Veterinary medicine is undergoing a technological revolution, driven by advancements in AI, IoT, and sensor-based systems.